Published in Support Care Cancer on February 17, 2012
Predictors of anxiety and depression in people with colorectal cancer. Support Care Cancer (2014) 0.95
The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up. Support Care Cancer (2013) 0.78
Suicide Screening in the Oncology Population. J Adv Pract Oncol (2016) 0.77
Towards a new conceptualization of depression in older adult cancer patients: a review of the literature. Aging Ment Health (2015) 0.75
Association between Daytime Activity, Fatigue, Sleep, Anxiety, Depression, and Symptom Burden in Advanced Cancer Patients: A Preliminary Report. J Palliat Med (2016) 0.75
A modified Edmonton Symptom Assessment Scale for symptom clusters in radiation oncology patients. Cancer Med (2017) 0.75
The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med (2001) 76.04
Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol (1982) 43.81
Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med (2010) 29.06
Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med (2000) 12.83
The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care (1991) 7.28
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol (2011) 4.38
Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res (1999) 4.38
Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer (2009) 3.79
Validation of the Edmonton Symptom Assessment Scale. Cancer (2000) 3.56
Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer (2001) 2.74
Oncologists' recognition of depression in their patients with cancer. J Clin Oncol (1998) 2.69
Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int (2009) 2.30
Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med (2002) 1.85
Management of distress in cancer patients. J Support Oncol (2010) 1.71
The evaluation of the Center for Epidemiologic Studies Depression (CES-D) scale: Depressed and Positive Affect in cancer patients and healthy reference subjects. Qual Life Res (2000) 1.65
Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res (2000) 1.58
Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol (2002) 1.50
Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer (2005) 1.43
A review of the reliability and validity of the Edmonton Symptom Assessment System. Curr Oncol (2009) 1.43
Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage (2010) 1.37
Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management. Psychooncology (1998) 1.25
Somatic symptoms in patients with cancer experiencing pain or depression: prevalence, disability, and health care use. Arch Intern Med (2010) 1.22
Pain, depression, and fatigue as a symptom cluster in advanced cancer. J Pain Symptom Manage (2011) 1.22
Assessment of depression in cancer patients. J Natl Cancer Inst Monogr (2004) 1.21
The Edmonton staging system for cancer pain: preliminary report. Pain (1989) 1.21
Psychosocial interventions for patients with advanced cancer - a systematic review of the literature. Br J Cancer (2004) 1.21
Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. J Natl Compr Canc Netw (2010) 1.21
Acceptability of common screening methods used to detect distress and related mood disorders-preferences of cancer specialists and non-specialists. Psychooncology (2008) 1.19
How do palliative medicine physicians assess and manage depression. Palliat Med (2004) 1.19
Depression in palliative care: a pragmatic report from the Expert Working Group of the European Association for Palliative Care. Support Care Cancer (2001) 1.18
A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer (2011) 1.17
The treatment of depression in cancer patients: a systematic review. Support Care Cancer (2006) 1.15
Are cancer pain and depression interdependent? A systematic review. Psychooncology (2009) 1.09
A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer (2010) 1.08
The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med (2006) 1.06
Longitudinal study of depressive symptoms in patients with metastatic gastrointestinal and lung cancer. J Clin Oncol (2010) 1.05
Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool. Psychooncology (1999) 1.05
Screening for major depression in cancer outpatients: the diagnostic accuracy of the 9-item patient health questionnaire. Cancer (2010) 1.03
Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis. Palliat Med (2010) 1.02
Depression--an independent predictor of early death in patients with advanced cancer. J Affect Disord (2008) 1.00
Can the global uptake of palliative care innovations be improved? Insights from a bibliometric analysis of the Edmonton Symptom Assessment System. Palliat Med (2010) 1.00
A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat Med (2004) 0.98
Evaluating the quality of psychosocial care in outpatient medical oncology settings using performance indicators. Psychooncology (2010) 0.98
Assessing depression in palliative care patients using the visual analogue scale: a pilot study. Eur J Cancer Care (Engl) (1999) 0.97
The association of physical and psychological symptom burden with time to death among palliative cancer outpatients. J Pain Symptom Manage (2008) 0.97
Identifying patients at risk for, and treatment of major psychiatric complications of cancer. Support Care Cancer (1995) 0.92
Depression assessment and classification in palliative cancer patients: a systematic literature review. Palliat Med (2009) 0.90
The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. J Affect Disord (2006) 0.89
Revisiting depression in palliative care settings: the need to focus on clinical utility over validity. Palliat Med (2008) 0.87
Frequency of reporting and predictive factors for anxiety and depression in patients with advanced cancer. Clin Oncol (R Coll Radiol) (2011) 0.81
Fatigue in advanced cancer patients attending an outpatient palliative radiotherapy clinic as screened by the Edmonton Symptom Assessment System. Support Care Cancer (2011) 0.81
Depressive symptoms in advanced cancer. Part 1. Assessing depression: the Mood Evaluation Questionnaire. Palliat Med (2003) 0.80
Depression assessment by oncologists and palliative care physicians. Palliat Support Care (2012) 0.76
[Translation and validation of Brief Edinburgh Depression Scale (BEDS) in French]. Bull Cancer (2011) 0.75
Review: screening or case-finding questionnaires used alone are not effective in the management of depression. ACP J Club (2008) 0.75
Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78
Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol (2013) 5.07
Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain (2006) 4.96
Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst (2007) 4.55
Availability and integration of palliative care at US cancer centers. JAMA (2010) 4.51
Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology. J Clin Oncol (2009) 3.36
Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2009) 3.33
A training program for anthropometric measurements by a dedicated nutrition support team improves nutritional status assessment of the critically ill child. Pediatr Crit Care Med (2015) 2.63
Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer (2009) 2.58
Socioeconomic inequalities and oral cancer risk: a systematic review and meta-analysis of case-control studies. Int J Cancer (2008) 2.57
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res (2009) 2.51
Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer (2011) 2.15
Dehydration in cancer patients: to treat or not to treat. J Support Oncol (2004) 2.15
The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med (2013) 2.00
Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer (2010) 1.97
Delirium in advanced cancer patients. Palliat Med (2004) 1.92
Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med (2008) 1.76
Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. Cancer (2006) 1.75
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain (2006) 1.72
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine (2004) 1.70
Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol (2009) 1.70
Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med (2005) 1.67
Patient-physician communication about code status preferences: a randomized controlled trial. Cancer (2013) 1.66
NCCN clinical practice guidelines in oncology: palliative care. J Natl Compr Canc Netw (2009) 1.66
Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist (2011) 1.61
Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. J Clin Oncol (2013) 1.59
An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer (2010) 1.59
The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med (2010) 1.57
Palliative management of fatigue at the close of life: "it feels like my body is just worn out". JAMA (2007) 1.57
Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings of a prospective, longitudinal cohort study. Cancer (2015) 1.56
Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol (2004) 1.55
Inpatient rehabilitation improved functional status in asthenic patients with solid and hematologic malignancies. Am J Phys Med Rehabil (2011) 1.54
Does androgen stimulation prior to hypospadias surgery increase the rate of healing complications? - A preliminary report. J Pediatr Urol (2010) 1.53
Congenital versus acquired solitary kidney: is the difference relevant? Nephrol Dial Transplant (2010) 1.50
Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer (2014) 1.49
Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center. J Palliat Med (2010) 1.48
Cancer patients' perceptions regarding the value of the physical examination: a survey study. Cancer (2014) 1.44
Dual kidney transplantation from uncontrolled deceased donors after cardiac arrest: a possible option. Int J Urol (2013) 1.40
The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report. J Palliat Med (2014) 1.39
Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage (2010) 1.37
Access to palliative care among patients treated at a comprehensive cancer center. Oncologist (2012) 1.34
NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 1.34
Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med (2007) 1.32
Breakthrough cancer pain: an observational study of 1000 European oncology patients. J Pain Symptom Manage (2013) 1.32
Quantity, design, and scope of the palliative oncology literature. Oncologist (2011) 1.32
Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer (2009) 1.30
The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage (2011) 1.30
Pain and emotional distress in leukemia patients at diagnosis. Leuk Res (2009) 1.26
Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer (2004) 1.25
The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist (2011) 1.24
A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician (2012) 1.24
Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer. Cancer Res (2011) 1.23
Spirituality, religiosity, and spiritual pain in advanced cancer patients. J Pain Symptom Manage (2011) 1.23
Targeted agent use in cancer patients at the end of life. J Pain Symptom Manage (2012) 1.22
Symptom control in palliative care--Part II: cachexia/anorexia and fatigue. J Palliat Med (2006) 1.22
Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol (2009) 1.22
Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother (2004) 1.22
Assessing hope at the end of life: validation of an experience of hope scale in advanced cancer patients. Palliat Support Care (2004) 1.20
Consensus guideline on parenteral methadone use in pain and palliative care. Palliat Support Care (2008) 1.20
Can this patient be discharged home? Factors associated with at-home death among patients with cancer. J Clin Oncol (2011) 1.20
Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol (2008) 1.19
Type of alcoholic beverage and risk of head and neck cancer--a pooled analysis within the INHANCE Consortium. Am J Epidemiol (2008) 1.19
Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model. Cancer (2010) 1.19
Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med (2009) 1.18
Body mass index and risk of head and neck cancer in a pooled analysis of case-control studies in the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Int J Epidemiol (2010) 1.18
A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer (2011) 1.17
Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med (2008) 1.17
Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. J Palliat Med (2008) 1.15
Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center. J Palliat Med (2007) 1.14
Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer (2014) 1.14
NOPPAIN: a nursing assistant-administered pain assessment instrument for use in dementia. Dement Geriatr Cogn Disord (2004) 1.14
Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer (2009) 1.13
Symptom control in palliative care--Part III: dyspnea and delirium. J Palliat Med (2006) 1.13
Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer (2004) 1.12
Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med (2008) 1.12
Involuntary smoking and head and neck cancer risk: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev (2008) 1.11
Opioid switching: a systematic and critical review. Cancer Treat Rev (2006) 1.10
Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. J Palliat Med (2013) 1.10
The impact of palliative care consultation on symptom assessment, communication needs, and palliative interventions in pediatric patients with cancer. J Palliat Med (2009) 1.09
The assessment and management of delirium in cancer patients. Oncologist (2009) 1.08
Botulinum toxin injection and phenol nerve block for reduction of end-of-life pain. J Palliat Med (2013) 1.08
Dual opioid therapy using methadone as a coanalgesic. Expert Opin Drug Saf (2014) 1.08
Symptom control in palliative care--Part I: oncology as a paradigmatic example. J Palliat Med (2006) 1.08
Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer (2011) 1.07
The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med (2006) 1.06
Phase I dose-escalation study of intravenous aflibercept in combination with docetaxel in patients with advanced solid tumors. Clin Cancer Res (2012) 1.06
Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer (2008) 1.06
Concepts and definitions for "supportive care," "best supportive care," "palliative care," and "hospice care" in the published literature, dictionaries, and textbooks. Support Care Cancer (2012) 1.06
Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev (2007) 1.05
Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. Oncoimmunology (2012) 1.05
Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival. J Clin Oncol (2002) 1.05
Parents dying of cancer and their children. Palliat Support Care (2004) 1.04
[For a coordination of the supportive care for people affected by severe illnesses: proposition of organization in the public and private health care centres]. Bull Cancer (2004) 1.03
Racial disparities in the use of hospice services according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer (2010) 1.03
Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. J Pain Symptom Manage (2009) 1.02
Clinical response to an outpatient palliative care consultation in patients with advanced cancer and cancer pain. J Pain Symptom Manage (2012) 1.02
The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. J Palliat Med (2012) 1.02
Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manage (2004) 1.02
Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther (2010) 1.02
Risk of lung cancer and past use of cannabis in Tunisia. J Thorac Oncol (2006) 1.00